Home > Income Statement > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Revenue

    Back to Income Statement
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,051 Cr₹134,033 Cr₹1,320 Cr₹1,010 Cr₹834 Cr

What is the latest Revenue of SUVEN PHARMACEUTICALS ?

The latest Revenue ratio of SUVEN PHARMACEUTICALS is ₹1,051 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,051 Cr
Mar2024₹134,033 Cr
Mar2023₹1,320 Cr
Mar2022₹1,010 Cr
Mar2021₹834 Cr

How is Revenue of SUVEN PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹1,051 Cr
-99.22
Mar2024 ₹134,033 Cr
10,052.30
Mar2023 ₹1,320 Cr
30.75
Mar2022 ₹1,010 Cr
21.10
Mar2021 ₹834 Cr -

Compare Revenue of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹34,795.6 Cr -7.6% 1.7% -20.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,342.0 Cr 3.4% 1.3% -11.6% Stock Analytics
DIVIS LABORATORIES ₹164,555.0 Cr 2.4% 3.2% 11.9% Stock Analytics
CIPLA ₹127,259.0 Cr 1.8% 1.9% -5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,898.0 Cr 2.8% -0.9% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹110,394.0 Cr 1.7% 6.2% -0.3% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-7.6%

1.7%

-20.9%

SENSEX

0.9%

1.2%

-0.4%


You may also like the below Video Courses